Femasys (FEMY) Net Income Growth (3y) (2023 - 2025)
Femasys (FEMY) Net Income Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.25 Bn | 121.03 Bn | 1.96 Bn | 24.56% |
| 2 | Becton Dickinson | 44.77 Bn | 43.96 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.95 Bn | 31.29 Bn | 1.53 Bn | 2.79% |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 19.70% |
| 6 | West Pharmaceutical Services | 23.51 Bn | 23.07 Bn | 329.20 Mn | -0.49% |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | -64.60% |
| 8 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | -58.17% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 8.69% |
| 10 | Femasys | 14.14 Mn | 8.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -17.30% |
| Mar 31, 2025 | -26.90% |
| Dec 31, 2024 | -29.40% |
| Sep 30, 2024 | -33.77% |
| Jun 30, 2024 | -62.93% |
| Mar 31, 2024 | -25.29% |
| Dec 31, 2023 | -38.52% |
| Sep 30, 2023 | -36.59% |
| Jun 30, 2023 | -24.89% |